Both glutamate receptor antagonists and prefrontal cortex lesions prevent induction of cocaine sensitization and associated neuroadaptations

Synapse

Volumn 34, Issue 3, 1999, Pages 169-180

  Li, Yong ^a   Hu, Xiu Ti ^a   Berney, Timothy G ^a   Vartanian, A John ^a   Stine, Christy D ^a   Wolf, Marina E ^a   White, Francis J ^a  

^a ROSALIND FRANKLIN UNIVERSITY OF MEDICINE AND SCIENCE   (United States)

Author keywords

Dopamine; Dopamine D1 receptors; Dopamine D2 receptors; Excitatory amino acids; Nucleus accumbens; Ventral tegmental area

Indexed keywords

4 PHOSPHONOMETHYLPIPECOLIC ACID; 6 NITRO 7 SULFAMOYLBENZO[F]QUINOXALINE 2,3 DIONE; COCAINE; DIZOCILPINE; DOPAMINE; DOPAMINE 1 RECEPTOR; DOPAMINE 2 RECEPTOR; EXCITATORY AMINO ACID; GLUTAMATE RECEPTOR ANTAGONIST; IBOTENIC ACID;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BRAIN CORTEX LESION; CONTROLLED STUDY; DOPAMINERGIC SYSTEM; DRUG SENSITIZATION; LOCOMOTION; MALE; NEUROTRANSMISSION; NONHUMAN; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; PRIORITY JOURNAL; RAT; RECEPTOR SENSITIVITY; SINGLE UNIT ACTIVITY; VENTRAL TEGMENTUM;

ADAPTATION, BIOLOGICAL; ANIMALS; COCAINE-RELATED DISORDERS; EXCITATORY AMINO ACID ANTAGONISTS; LOCOMOTION; MALE; NEURONS; NUCLEUS ACCUMBENS; PREFRONTAL CORTEX; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, DOPAMINE; VENTRAL TEGMENTAL AREA;

EID: 0032734707     PISSN: 08874476     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1098-2396(19991201)34:3<169::AID-SYN1>3.0.CO;2-C     Document Type: Article

References (92)

1. Abekawa T, Ohmori T, Koyama T. 1995. Effects of nitric oxide (NO) synthesis inhibition on the development of supersensitivity to stereotypy and locomotion stimulating effects of methamphetamine. Brain Res 679:200-204.
2. Ackerman JM, White FJ. 1990. A10 somatodendritic dopamine autoreceptor sensitivity following withdrawal from repeated cocaine treatment. Neurosci Lett 117:181-187.
3. Berhow MT, Hiroi N, Nestler EJ. 1996. Regulation of ERK (extracellular signal regulated kinase), part of the neurotrophin signal transduction cascade, in the rat mesolimbic dopamine system by chronic exposure to morphine or cocaine. J Neurosci 16:4707-4715.
4. 1 receptors of the ventral tegmental area in the behavioral sensitization induced by intra-ventral tegmental area injections of D-amphetamine. J Pharmacol Exp Ther 277:1177-1187.
5. Bonci A, Williams JT. 1996. A common mechanism mediates long-term changes in synaptic transmission after chronic cocaine and morphine. Neuron 16:631-639.
6. Cador M, Bjijou Y, Stinus L. 1995. Evidence of a complete independence of the neurobiological substrates for the induction and expression of behavioral sensitization to amphetamine. Neuroscience 65:385-395.
7. Cador M, Bjijou Y, Cailhol S, Stinus L. 1997. Role of a glutamatergic prefrontal/VTA innervation on amphetamine-induced behavioral sensitization to amphetamine. Soc Neurosci Abstr 23:1093.
8. Calabresi P, Maj R, Pisani A, Mercuri NB, Bernardi G. 1992. Long-term synaptic depression in the striatum: physiological and pharmacological characterization. J Neurosci 12:4224-4233.
9. Churchill L, Ghasemzadeh MB, Kalivas P. 1997. Glutamate receptor subunits (GluR1 and NMDAR1) increase in the nucleus accumbens of rats 3 weeks after repeated cocaine exposure. Soc Neurosci Abstr 23:260.
10. Cunningham ST, Kelley AE. 1993. Hyperactivity and sensitization to psychostimulants following cholera toxin infusion into the nucleus accumbens. J Neurosci 13:2342-2350.
11. Delfs JM, Schreiber L, Kelley AE. 1990. Microinjection of cocaine into the nucleus accumbens elicits locomotor activation in the rat. J Neurosci 10:303-310.
12. Fitzgerald LW, Nestler EJ. 1995. Cocaine regulation of signal transduction pathways. In: Hammer RP Jr, editor. The neurobiology of cocaine: cellular and molecular mechanisms. Boca Raton, FL: CRC Press. p 225-246.
13. Fitzgerald LW, Ortiz J, Hamedani AG, Nestler EJ. 1996. Drugs of abuse and stress increase the expression of GluR1 and NMDAR1 glutamate receptor subunits in the rat ventral tegmental area: common adaptations among cross-sensitizing agents. J Neurosci 16:274-282.
14. Garcia-Munoz M, Patino P, Masliah E, Young SJ, Groves PM. 1996. Glutamate-dependent long-term presynaptic changes in corticostriatal excitability. Neuroscience 73:109-119.
15. Ghasemzadeh MB, Nelson LC, Kalivas P. 1999. Neuroadaptations in ionotropic and metabotropic glutamate receptor mRNA produced by cocaine treatment. J Neurochem 72:157-165.
16. Goeders NE, Smith JE. 1983. Cortical dopaminergic involvement in cocaine reinforcement. Science 221:773-775.
17. Goeders NE, Dworkin SI, Smith JE. 1986. Neuropharmacological assessment of cocaine self-administration into the medial prefrontal cortex. Pharmacol Biochem Behav 24:1429-1440.
18. Guitart X, Hayward M, Nisenbaum LK, Beitner-Johnson D, Haycock JW, Nestler EJ. 1990. Identification of MARPP-58, a morphine- and cyclic AMP-regulated phosphoprotein of 58 kDa, as tyrosine hydroxylase: evidence for regulation of its expression by chronic morphine in the rat locus coeruleus. J Neurosci 10:2649-2659.
19. Haracz JL, Belanger SA, MacDonall JS, Sircar R. 1995. Antagonists of N-methyl-D-aspartate receptors partially prevent the development of cocaine sensitization. Life Sci 57:2347-2357.
20. Haracz JL, MacDonall JS, Sircar R. 1997. Effects of nitric oxide synthase inhibitors on cocaine sensitization. Brain Res 746:183-189.
21. Healy DJ, Meador-Woodruff JH. 1996. Differential regulation, by MK-801, of dopamine receptor gene expression in rat nigrostriatal, mesocorticolimbic systems. Brain Res 708:38-44.
22. Henry DJ, White FJ. 1991. Repeated cocaine administration causes persistent enhancement of D1 dopamine receptor sensitivity within the rat nucleus accumbens. J Pharmacol Exp Ther 258:882-890.
23. Henry DJ, White FJ. 1995. The persistence of behavioral sensitization to cocaine parallels enhanced inhibition of nucleus accumbens neurons. J Neurosci 15:6287-6299.
24. Henry DJ, Greene MA, White FJ. 1989. Electrophysiological effects of cocaine in the mesoaccumbens dopamine system: repeated administration. J Pharmacol Exp Ther 251:833-839.
25. Hooks MS, Jones GH, Liem BJ, Justice JB Jr. 1992. Sensitization and individual differences to IP amphetamine, cocaine, or caffeine following repeated intracranial amphetamine infusions. Pharmacol Biochem Behav 43:815-823.
26. Ida I, Asami T, Kuribara H. 1995. Inhibition of cocaine sensitization by MK-801, a noncompetitive N-methyl-D-aspartate (NMDA) receptor antagonist: evaluation by ambulatory activity in mice. Jpn J Pharmacol 69:83-90.
27. G-nitro-L-arginine methyl ester attenuates the maintenance and expression of methamphetamine-induced behavioral sensitization and enhancement of striatal dopamine release. J Pharmacol Exp Ther 277:1424-1430.
28. Itzhak Y. 1997. Modulation of cocaine- and methamphetamine-induced behavioral sensitization by inhibition of brain nitric oxide synthase. J Pharmacol Exp Ther 282:521-527.
29. Jeziorski M, White FJ, Wolf ME. 1994. MK-801 prevents the development of behavioral sensitization during repeated morphine administration. Synapse 16:137-147.
30. Kalivas PW. 1995. Neural basis of behavioral sensitization to cocaine. In: Hammer RP Jr, editor. The neurobiology of cocaine: cellular and molecular mechanisms. Boca Raton, FL: CRC Press. p 81-98.
31. Kalivas PW, Alesdatter JE. 1993. Involvement of N-methyl-D-aspartate receptor stimulation in the ventral tegmental area and amygdala in behavioral sensitization to cocaine. J Pharmacol Exp Ther 267:486-495.
32. 1 receptors modulate glutamate transmission in the ventral tegmental area. J Neurosci 15:5379-5388.
33. Kalivas PW, Weber B. 1988. Amphetamine injection into the ventral mesencephalon sensitizes rats to peripheral amphetamine and cocaine. J Pharmacol Exp Ther 245:1095-1102.
34. Karler R, Calder LD, Chaudhry IA, Turkanis SA. 1989. Blockade of "reverse tolerance" to cocaine and amphetamine by MK-801. Life Sci 45:599-606.
35. Karler R, Calder LD, Bedingfield JB. 1994. Cocaine behavioral sensitization and the excitatory amino acids. Psychopharmacology (Berl) 115:305-310.
36. Karler R, Bedingfield JB, Thai DK, Calder LD. 1997. The role of the frontal cortex in the mouse in behavioral sensitization to amphetamine. Brain Res 757:228-235.
37. Khan MA, Shoaib M. 1996. Neuroanatomical localization of the effects of (+)-HA966 on locomotor activity after cocaine injections to the nucleus accumbens of rats. Brain Res 719:198-202.
38. Kim HS, Park WK. 1995. Nitric oxide mediation of cocaine-induced dopaminergic behaviors: ambulation-accelerating activity, reverse tolerance and conditioned place preference in mice. J Pharmacol Exp Ther 275:551-557.
39. Kolta MG, Shreve P, Uretsky NJ. 1989. Effect of pretreatment with amphetamine on the interaction between amphetamine and dopamine neurons in the nucleus accumbens. Neuropharmacology 28: 9-14.
40. Kombian SB, Malenka RC. 1994. Simultaneous LTP of non-NMDA- and LTD of NMDA-receptor-mediated responses in the nucleus accumbens. Nature 368:242-246.
41. 2 receptor antagonists in terms of ambulation in mice. Pharmacol Biochem Behav 51:799-805.
42. Kuribara H, Uchihashi Y. 1993. Dopamine antagonists can inhibit methamphetamine sensitization, but not cocaine sensitization, when assessed by ambulatory activity in mice. J Pharm Pharmacol 45:1042-1045.
43. Li Y, Wolf ME. 1997. Ibotenic acid lesions of prefrontal cortex do not prevent expression of behavioral sensitization to amphetamine. Behav Brain Res 84:285-289.
44. Li Y, Vartanian J, White FJ, Xue CJ, Wolf ME. 1997. Effects of the AMPA receptor antagonist NBQX on the development and expression of behavioral sensitization to cocaine and amphetamine. Psychopharmacology 134:266-276.
45. Lu WX, Wolf ME. 1997. Repeated amphetamine administration alters AMPA receptor subunit expression in rat nucleus accumbens and medial prefrontal cortex. Synapse 32:119-131.
46. Lu WX, Chen HY, Xue CJ, Wolf ME. 1997. Repeated amphetamine administration alters the expression of mRNA for AMPA receptor subunits in rat nucleus accumbens and prefrontal cortex. Synapse 26:269-280.
47. 2-receptor mechanisms. Neurosci Lett 217:73-76.
48. 2 receptors does not block the development of behavioral sensitization to cocaine. Psychopharmacology (Berl) 114: 239-242.
49. Mattingly BA, Rowlett JK, Ellison T, Rase K. 1996. Cocaine-induced behavioral sensitization: effects of haloperidol and SCH 23390 treatments. Pharmacol Biochem Behav 53:481-486.
50. Morrow BA, Taylor JR, Roth RH. 1995. R-(+)-HA-966, an antagonist for the glycine/NMDA receptor, prevents locomotor sensitization to repeated cocaine exposures. Brain Res 673:165-169.
51. oa in discrete regions of rat brain. J Neurochem 55:1079-1082.
52. Paulson PE, Robinson TE. 1991. Sensitization to systemic amphetamine produces an enhanced locomotor response to a subsequent intra-accumbens amphetamine challenge in rats. Psychopharmacology 104:140-141.
53. Paxinos G, Watson C. 1986. The rat brain in stereotaxic coordinates. New York: Academic Press.
54. Perugini M, Vezina P. 1994. Amphetamine administered to the ventral tegmental area sensitizes rats to the locomotor effects of nucleus accumbens amphetamine. J Pharmacol Exp Ther 270:690-696.
55. Pierce RC, Bell K, Duffy P, Kalivas PW. 1996a. Repeated cocaine augments excitatory amino acid transmission in the nucleus accumbens only in rats having developed behavioral sensitization. J Neurosci 16:1550-1560.
56. Pierce RC, Born B, Adams M, Kalivas PW. 1996b. Repeated intraventral tegmental area administration of SKF-38393 induces behavioral and neurochemical sensitization to a subsequent cocaine challenge. J Pharmacol Exp Ther 278:384-392.
57. Pierce RC, Reeder DC, Hicks J, Morgan ZR, Kalivas PW. 1998. Ibotenic acid lesions of the dorsal prefrontal cortex disrupt the expression of behavioral sensitization to cocaine. Neuroscience 82:1103-1114.
58. Pijnenburg AJJ, Honig WMM, Van der Heyden JAM, Van Rossum JM. 1976. Effects of chemical stimulation of the mesolimbic dopamine system upon locomotor activity. Eur J Pharmacol 35:45-58.
59. Post RM, Weiss SRB, Pert A. 1992. Sensitization and kindling effects of chronic cocaine administration. In: Lakoski JM, Galloway MP, White FJ, editors. Cocaine: pharmacology, physiology and clinical strategies. Boca Raton, FL: CRC Press. p 115-161.
60. Pudiak CM, Bozarth MA. 1993. L-NAME and MK-801 attenuate sensitization to the locomotor-stimulating effect of cocaine. Life Sci 53:1517-1524.
61. Robinson TE, Berridge KC. 1993. The neural basis of drug craving: an incentive-sensitization theory of addiction. Brain Res Rev 18:247-291.
62. Schenk S, Snow S. 1994. Sensitization to cocaine's motor activating properties produced by electrical kindling of the medial prefrontal cortex but not of the hippocampus. Brain Res 659:17-22.
63. Sesack SR, Pickel VM. 1992. Prefrontal cortical efferents in the rat synapse on unlabeled neuronal targets of catecholamine terminals in the nucleus accumbens septi and on dopamine neurons in the ventral tegmental area. J Comp Neurol 320:145-160.
64. Sesack SR, Deutch AY, Roth RH, Bunney BS. 1989. Topographical organization of the efferent projections of the medial prefrontal cortex in the rat: an anterograde tract-tracing study with Phaseolus vulgaris leucoagglutinin. J Comp Neurol 290:213-242.
65. Shoaib M, Shippenberg TS, Goldberg SR, Schindler CW. 1995. Behavioral studies with the glycine partial agonist (+)-HA966 on cocaine-induced locomotor activity and reinforcement. Behav Pharmacol 6:568-576.
66. Sorg BA, Kalivas P. 1993. Effects of cocaine and footshock stress on extracellular dopamine levels in the medial prefrontal cortex. Neuroscience 53:895-703.
67. Sorg BA, Davidson DL, Kalivas PW, Prasad BM. 1997. Repeated daily cocaine alters subsequent cocaine-induced increase of extracellular dopamine in the medial prefrontal cortex. J Pharmacol Exp Ther 281:54-61.
68. Steketee JD. 1998. Repeated injection of GBR 12909, but not cocaine or WIN 35-065-2, into the ventral tegmental area induces behavioral sensitization. Behav Brain Res 97:39-48.
69. Stewart J, Druhan JP. 1993. Development of both conditioning and sensitization of the behavioral activating effects of amphetamine is blocked by the non-competitive NMDA receptor antagonist MK-801. Psychopharmacology 110:125-132.
70. Stewart J, Deschamps SE, Amir S. 1994. Inhibition of nitric oxide synthase does not block the development of sensitization to the behavioral activating effects of amphetamine. Brain Res 641:141-144.
71. Striplin CD, Kalivas PW. 1993. Robustness of G protein changes in cocaine sensitization shown with immunoblotting. Synapse 14: 10-15.
72. Tong Z-Y, Overton PG, Clark D. 1995. Chronic administration of (+)-amphetamine alters the reactivity of midbrain dopaminergic neurons to prefrontal cortex stimulation in the rat. Brain Res 674:63-74.
73. 1 dopamine receptor activation is necessary for the induction of sensitization by amphetamine in the ventral tegmental area. J Neurosci 16:2411-2420.
74. Vezina P, Stewart J. 1989. The effect of dopamine receptor blockade on the development of sensitization to the locomotor activating effects of amphetamine and morphine. Brain Res 499:108-120.
75. Vezina P, Stewart J. 1990. Amphetamine administered into the ventral tegmental area but not to the nucleus accumbens sensitizes rats to systemic morphine: lack of conditioned effects. Brain Res 516:99-106.
76. Vezina P, Kalivas PW, Stewart J. 1987. Sensitization occurs to the locomotor effects of morphine and the specific μ opioid receptor agonist, DAGO, administered repeatedly to the ventral tegmental area but not to the nucleus accumbens. Brain Res 417:51-58.
77. White FJ. 1996. Synaptic regulation of mesocorticolimbic dopamine neurons. Annu Rev Neurosci 19:405-436.
78. White FJ, Wang RY. 1984. Electrophysiological evidence for A10 dopamine autoreceptor subsensitivity following chronic d-amphetamine treatment. Brain Res 309:283-292.
79. White FJ, Hu X-T, Zhang X-F, Wolf ME. 1995a. Repeated administration of cocaine or amphetamine alters neuronal responses to glutamate in the mesoaccumbens dopamine system. J Pharmacol Exp Ther 273:445-454.
80. White FJ, Hu X-T, Henry DJ, Zhang X-F. 1995b. Neurophysiological alterations in the mesocorticolimbic dopamine system during repeated cocaine administration. In: Hammer RP Jr, editor. The neurobiology of cocaine: cellular and molecular mechanisms. Boca Raton, FL: CRC Press. p 95-115.
81. White FJ, Hu X-T, Zhang X-F. 1997. Neuroadaptations in nucleus accumbens neurons resulting from repeated cocaine administration. In: Catecholamines: bridging basic science with clinical medicine. Goldstein D, Eisenhofer G, McCarty R, editors. San Diego: Academic Press. p 1006-1009.
82. White FJ, Joshi A, Koeltzow TE, Hu XT. 1998. Dopamine receptor antagonists fail to prevent induction of cocaine sensitization. Neuropsychopharmacology 18:26-40.
83. Wolf ME. 1998. The role of excitatory amino acids in behavioral sensitization to psychomotor stimulants. Prog Neurobiol 54:1-42.
84. Wolf ME, Jeziorski M. 1993. Coadministration of MK-801 with amphetamine, cocaine or morphine prevents rather than transiently masks the development of behavioral sensitization. Brain Res 613:291-294.
85. Wolf ME, Khansa MR. 1991. Repeated administration of MK-801 produces sensitization to its own locmotor stimulant effects but blocks sensitization to amphetamine. Brain Res 562:164-168.
86. Wolf ME, Xue CJ. 1998. Amphetamine and D1 receptor agonists produce biphasic effects on glutamate efflux in rat ventral tegmental area: modification by repeated amphetamine administration. J Neurochem 70:198-209.
87. Wolf ME, White FJ, Hu X-T. 1993. Behavioral sensitization to MK-801 (dizocilpine): neurochemical and electrophysiological correlates in the mesoaccumbens dopamine system. Behav Pharmacol 4:429-442.
88. Wolf ME, White FJ, Hu X-T. 1994. MK-801 prevents alterations in the mesoaccumbens dopamine system associated with behavioral sensitization to amphetamine. J Neurosci 14:1735-1745.
89. Wolf ME, Dahlin SL, Hu XT, Xue CJ, White K. 1995. Effects of lesions of prefrontal cortex, amygdala, or fornix on behavioral sensitization to amphetamine: comparison with N-methyl-D-aspartate antagonists. Neuroscience 69:417-439.
90. Xue CJ, Ng JP, Li Y, Wolf ME. 1996. Acute and repeated systemic amphetamine administration: Effects on extracellular glutamate, aspartate, and serine levels in rat ventral tegmental area and nucleus accumbens. J Neurochem 67:352-363.
91. Zhang XF, Hu XT, White FJ, Wolf ME. 1997. Increased responsiveness of ventral tegmental area dopamine neurons to glutamate after repeated administration of cocaine or amphetamine is transient and selectively involves AMPA receptors. J Pharmacol Exp Ther 281:699-706.
92. Zhang X-F, Hu X-T, White FJ. 1998. Whole-cell plasticity in cocaine withdrawal: reduced sodium current in nucleus accumbens neurons. J Neurosci 18:488-498.